Vivo Bio Tech logo

Vivo Bio Tech

VIVOBIOT NSE

Key Fundamentals

MicrocapBiotechnologyHealthcare
Market Cap
₹36.79 Cr
Volatility
Low Risk
P/E Ratio
-13.2
EBITDA
₹20.84 Cr
Return on Equity
9.35%
Debt to Equity
0.72
Book Value
₹41.25
52W High
₹20.94
52W Low
₹16.75

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 0.41 times its book value

Weaknesses

5
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -4.81%
  • The company has delivered a poor sales growth of 0.59% over past five years.
  • Promoter holding is low: 30.6%
  • Company has a low return on equity of 2.24% over last 3 years.

Growth Rate

Revenue Growth
3.55% higher than 3Y
Net Income Growth
-45.21% lower than 3Y
Cash Flow Change
-23.78% lower than 3Y
ROE
102% higher than 3Y
ROCE
18.36% higher than 3Y
EBITDA Margin (Avg.)
-21.19% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
11.58
9.26
12.85
11.76
10.13
12.04
12.21
12.29
12.51
13.11
13.51
14.2
14.28
Expenses
7.09
4.4
6.48
6.39
5.77
6.45
6.67
7.27
7.03
7.69
8.02
9.75
9.23
Operating Profit
4.49
4.86
6.37
5.37
4.36
5.59
5.54
5.02
5.48
5.42
5.49
4.45
5.05
OPM %
38.77%
52.48%
49.57%
45.66%
43.04%
46.43%
45.37%
40.85%
43.8%
41.34%
40.64%
31.34%
35.36%
Other Income
0
0
0.03
0.01
0.01
4.63
0.01
0.15
0.14
0.13
0.14
0.03
0.06
Interest
1.95
2.09
2.22
1.52
1.92
2.06
1.84
1.68
1.5
1.47
1.4
1.48
1.24
Depreciation
2.29
2.3
2.28
2.43
2.23
2.29
2.25
2.25
2.64
2.57
2.66
2.75
3.53
PBT
0.25
0.47
1.9
1.43
0.22
5.87
1.46
1.24
1.48
1.51
1.57
0.25
0.34
Tax %
44%
29.79%
31.05%
48.95%
27.27%
10.73%
43.84%
14.52%
9.46%
42.38%
20.38%
2164%
44.12%
Net Profit
0.14
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
-5.16
0.19
EPS in Rs
0.09
0.22
0.89
0.5
0.11
3.51
0.51
0.62
0.67
0.39
0.57
-2.33
0.09
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17.79
28.58
34.13
47
55.83
55.35
51.78
51.39
52.23
45.45
46.67
53.33
55.1
Expenses
14.99
24.87
26.51
36.11
46.32
42.88
33.98
35.3
30.39
24.19
26.11
32.48
34.69
Operating Profit
2.8
3.71
7.62
10.89
9.51
12.47
17.8
16.09
21.84
21.26
20.56
20.85
20.41
OPM %
15.74%
12.98%
22.33%
23.17%
17.03%
22.53%
34.38%
31.31%
41.82%
46.78%
44.05%
39.1%
37.04%
Other Income
0.95
0.89
0.4
0.13
0.01
0.05
0.08
0.1
0.04
0.04
4.8
0.44
0.36
Interest
0.51
0.47
1.29
2.37
2.64
3.1
3.67
4.27
7.99
7.95
7.55
5.85
5.59
Depreciation
3.05
3.35
3.9
4.64
5.06
5.17
5.59
7.45
9.27
9.29
9.02
10.63
11.51
PBT
0.19
0.78
2.83
4.01
1.82
4.25
8.62
4.47
4.62
4.06
8.79
4.81
3.67
Tax %
-142.11%
-16.67%
11.66%
21.95%
-23.08%
-4.47%
34.11%
50.78%
42.64%
37.93%
17.18%
135.55%
—
Net Profit
0.46
0.91
2.5
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
-1.71
-2.85
EPS in Rs
0.49
0.97
2.67
3.17
1.82
3.45
4.23
1.54
1.78
1.7
4.24
-0.77
-1.28
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9.35
9.35
9.35
9.85
12.35
12.89
13.42
14.26
14.9
14.9
17.16
22.19
Reserves
-0.18
0.71
3.22
9.46
14.92
20.14
29.11
32.87
36.97
39.5
60.74
70.97
Borrowings
5.69
16.91
27.06
25.12
21.68
24.37
30.96
67.44
62.39
73.06
54.03
67.38
Other Liabilities
26.57
18.69
11.49
15.08
6.37
6.29
6.03
7.91
8.77
9.67
11.3
17.89
Total Liabilities
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Fixed Assets
19.69
23.54
28.57
27.66
30.01
34.99
52.05
95.17
88.87
80.37
88.24
123
CWIP
0.07
0.04
2.96
3.94
0.07
0.15
0.32
0.87
1.9
9.21
12.84
4.81
Investments
0
0
0
0
0
0
0
0
0
0
0
21.91
Other Assets
21.67
22.08
19.59
27.91
25.24
28.55
27.15
26.44
32.26
47.55
42.15
28.69
Total Assets
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.25
8.81
-5.66
11.11
-0.78
8.61
14.18
16.64
14.83
15.52
11.83
—
Investing
-2.04
-7.2
-11.84
-4.72
-3.53
-10.23
-22.82
-51.11
-4
-7.95
-15.84
—
Financing
-0.89
-0.32
6.83
-3.43
0.72
2.09
8.78
35.02
-11.18
-7.56
3.9
—
Net Cash Flow
-0.68
1.3
-10.67
2.96
-3.59
0.47
0.14
0.55
-0.34
0.01
-0.11
—
Free Cash Flow
0.21
1.61
-17.5
6.39
-4.31
-1.62
-8.64
-34.47
10.83
7.57
-4.01
—
CFO/OP
81
234
-70
110
-13
68
96
118
77
80
65
—
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88.43
48.79
82.03
91.48
54.98
69.11
51.39
85.37
86.52
94.76
87.98
80.42
Inventory Days
558
169
204
289
256
451
672
313
430
831
491
366
Days Payable
814
363
242
304
152
167
70.37
74.02
50.68
100
61.78
88
Cash Conversion Cycle
-168
-145
44.36
76.61
159
354
653
324
466
826
517
358
Working Capital Days
-354
-131
19.25
-13.28
36.22
35.15
28.76
8.1
38.09
63.76
100
-22.24
ROCE %
4.67%
5.98%
12.37%
15.18%
9.55%
13.82%
18.78%
9.29%
11.02%
9.94%
9.04%
7.29%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vivo Bio Tech insights

57 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Others36.87%Promot.30.62%Public32.52%As ofJun 2026

Documents

Frequently Asked Questions about Vivo Bio Tech

What does Vivo Bio Tech Ltd do?
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]
Where is Vivo Bio Tech Ltd (511509) listed?
Vivo Bio Tech Ltd trades as VIVOBIOT on the NSE and under code 511509 on the BSE.
Which sector does Vivo Bio Tech Ltd belong to?
Vivo Bio Tech Ltd is classified under the Healthcare sector, in the Biotechnology industry.
What is the market capitalisation of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a market capitalisation of ₹36.79 Cr, which places it in the Small Cap band.
What is the PE ratio of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd trades at a PE ratio of -13.20, against a book value of ₹41.25 per share.
What is the 52-week high and low of Vivo Bio Tech Ltd?
Over the last 52 weeks Vivo Bio Tech Ltd has traded between ₹16.75 and ₹20.94.
What is the Return on Equity (ROE) of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd reported a return on equity of 9.35%. Its debt-to-equity ratio is 0.72.

Company Information

Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]

Website vivobio.com
Listed 2026-08-17
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/511509.md for Vivo Bio Tech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List